• M42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while Olive Rock Partners takes 100 per cent ownership of HealthPlus IVF & Women’s Health Abu Dhabi
• Strategic realignment of ownership and focus enables M42 to deepen impact on health outcomes through integrated, system-level healthcare delivery, while ORP focuses on dedicated investment, operational autonomy and strategic transformation
• The agreement ensures seamless continuity for patients, employees and partners

M42, a global health leader powered by artificial intelligence (AI), technology and genomics, has signed an agreement with Olive Rock Partners (ORP) that will see M42 assume full ownership of United Eastern Medical Services (UEMS), a key care provider within the UAE’s healthcare ecosystem that includes Danat Al Emarat hospital, Moorfields Eye Hospital Abu Dhabi, HealthPlus Family Health, HealthPlus Diabetes and Endocrionolgy and HealthPlus Diabetes Pharmacy.

In exchange, ORP will take full ownership of HealthPlus IVF and Women’s Health Abu Dhabi, including its pharmacy and genetics laboratory,

This strategic realignment gives both organizations full responsibility to deepen impact on health outcomes. For M42, full ownership of the UEMS portfolio enhances its ability to scale system-level healthcare delivery, accelerate innovation and deliver integrated, high-quality, data-driven care across the UAE health system. For ORP, complete ownership of HealthPlus IVF and Women’s Health Abu Dhabi enables dedicated investment, operational autonomy and strategic transformation.

Under the terms of the deal, M42 will acquire 100 per cent ownership of UEMS following the transfer of ORP’s 26.67 per cent equity stake, and a cash consideration to M42.

Dimitris Moulavasilis, Group Chief Executive Officer, M42, said: “This strategic realignment is a purposeful step in M42’s growth journey. It simplifies our structure, strengthens alignment across our care delivery assets, and enhances integration for elevated system-level performance. Taking full ownership of UEMS strengthens M42’s portfolio and positions us well to continue serving our patients and communities with quality, personalized care. We thank Olive Rock Partners for their trusted partnership over the years and our continued collaboration.”

Abdullah Shahin, Founding Partner at Olive Rock Partners, added: “We see enormous opportunity to advance fertility and women’s health. This step allows us to build on HealthPlus IVF and Women’s Health Abu Dhabi’s strong foundation by investing in clinical excellence, talent and strategic transformation for regional leadership. It has been a privilege to co-own UEMS alongside M42 and advance care in the UAE across different care specialties. We wish M42 the best in leading UEMS during the next stage of UEMS’ journey.”

Both M42 and ORP remained committed to seamless continuity for patients, employees and partners. There will be no disruption to services, and all teams continue to work together for a smooth transition.

The transaction was signed on July 25, 2025 and completed following receipt of final regulatory approvals and licensing arrangements.